Sorafenib for hepatocellular carcinoma patients beyond Milan criteria after orthotopic liver transplantation: a case control study

BACKGROUND: Orthotopic liver transplantation (OLT) is one of the most effective treatments for patients with hepatocellular carcinoma (HCC) within the Milan criteria. However, for patients beyond these criteria, the recurrence rate is higher and the prognosis is worse. Sorafenib is the only drug sho...

Descripción completa

Detalles Bibliográficos
Autores principales: Teng, Chieh-Lin, Hwang, Wen-Li, Chen, Yi-Ju, Chang, Kuang-Hsi, Cheng, Shao-Bin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3359192/
https://www.ncbi.nlm.nih.gov/pubmed/22339891
http://dx.doi.org/10.1186/1477-7819-10-41

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3359192/
https://www.ncbi.nlm.nih.gov/pubmed/22339891
http://dx.doi.org/10.1186/1477-7819-10-41

Ejemplares similares